| Comprehensive analysis of genetic ancestry and its molecular correlates in cancer J Carrot-Zhang, N Chambwe, JS Damrauer, TA Knijnenburg, ... Cancer Cell 37 (5), 639-654. e6, 2020 | 226 | 2020 |
| mTOR inhibition restores amino acid balance in cells dependent on catabolism of extracellular protein M Nofal, K Zhang, S Han, JD Rabinowitz Molecular cell 67 (6), 936-946. e5, 2017 | 93 | 2017 |
| Detection of pathogenic variants with germline genetic testing using deep learning vs standard methods in patients with prostate cancer and melanoma SH AlDubayan, JR Conway, SY Camp, L Witkowski, E Kofman, ... JAMA 324 (19), 1957-1969, 2020 | 39 | 2020 |
| Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes R Gillani, SY Camp, S Han, JK Jones, H Chu, S O’Brien, EL Young, ... The American Journal of Human Genetics 109 (6), 1026-1037, 2022 | 34 | 2022 |
| GCN2 adapts protein synthesis to scavenging-dependent growth M Nofal, T Wang, L Yang, CSR Jankowski, SHJ Li, S Han, L Parsons, ... Cell Systems 13 (2), 158-172. e9, 2022 | 21 | 2022 |
| Integrative Analysis of Germline Rare Variants in Clear and Non–clear Cell Renal Cell Carcinoma SH Han, SY Camp, H Chu, R Collins, R Gillani, J Park, Z Bakouny, ... European Urology Open Science 62, 107-122, 2024 | 4 | 2024 |
| Mutational footprint of platinum chemotherapy in a secondary thyroid cancer J Schiantarelli, T Pappa, J Conway, J Crowdis, B Reardon, F Dietlein, ... JCO Precision Oncology 6, e2200183, 2022 | 4 | 2022 |
| Analytical protocol to identify local ancestry-associated molecular features in cancer J Carrot-Zhang, S Han, W Zhou, JS Damrauer, A Kemal, AC Berger, ... STAR protocols 2 (4), 100766, 2021 | 4 | 2021 |
| Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients M Al-Jumaan, H Chu, A Alsulaiman, SY Camp, S Han, R Gillani, ... Genome Medicine 15 (1), 65, 2023 | 2 | 2023 |
| Somatic structural variants drive distinct modes of oncogenesis in melanoma JR Conway, R Gillani, J Crowdis, B Reardon, J Park, SH Han, BM Titchen, ... The Journal of Clinical Investigation, 2024 | 1 | 2024 |
| Analysis of evolutionary dynamics and clonal architecture in prostate cancer JR Conway, AK Tewari, SY Camp, S Han, J Crowdis, MX He, YA Nyame, ... bioRxiv, 2023.03. 23.533974, 2023 | 1 | 2023 |
| Analysis of germline-driven ancestry-associated gene expression in cancers N Chambwe, RW Sayaman, D Hu, S Huntsman, J Carrot-Zhang, ... STAR protocols 3 (3), 101586, 2022 | 1 | 2022 |
| Expanding the diagnostic yield of germline genetic testing in cancer patients using deep learning. SH Aldubayan, J Conway, L Witkowski, E Kofman, B Reardon, S Camp, ... Journal of Clinical Oncology 38 (15_suppl), 1518-1518, 2020 | 1 | 2020 |
| Abstract P01: Impact of Germline and Somatic ATM Variants in Chronic Lymphocytic Leukemia (CLL): Clinical Implications and Response to PARP Inhibition K Mashima, N Moore, M Mikhaleva, A Petráčková, S Shupe, ... Blood Cancer Discovery 5 (2_Supplement), P01-P01, 2024 | | 2024 |
| Patient-partnered research enables germline characterization of angiosarcoma predisposition genes H Chu, M Hollyer, S Han, SY Camp, R Gillani, E Van Allen, N Wagle, ... Cancer Research 83 (7_Supplement), 6064-6064, 2023 | | 2023 |
| Low-pass Whole Genome Imputation Enables the Characterization of Polygenic Breast Cancer Risk in the Indigenous Arab Population M Al-Jumaan, H Chu, A Al-Sulaiman, SY Camp, S Han, R Gillani, ... medRxiv, 2022.12. 07.22282785, 2022 | | 2022 |
| Characteristics of Rare Germline ATM Variants in Chronic Lymphocytic Leukemia (CLL) K Mashima, BL Lampson, A Gupta, N Moore, A Petrackova, SJ Shupe, ... Blood 140 (Supplement 1), 9853-9854, 2022 | | 2022 |
| Patients with Deleterious Germline Variants in STXBP2 Develop Toxicity after CAR-T Cell Therapy with Axicabtagene Ciloleucel MB Leick, S Han, KME Gallagher, H Silva, G Martin, S Camp, H Chu, ... Blood 140 (Supplement 1), 646-647, 2022 | | 2022 |
| Evaluating pathogenic germline variants in checkpoint kinase 2 (CHEK2) in ovarian germ cell tumors SY Camp, S Han, SH AlDubayan, EM Van Allen Cancer Research 80 (16_Supplement), 2125-2125, 2020 | | 2020 |
